Technical Data
029373
SOD3 (Extracellular Superoxide Dismutase [Cu-Zn], EC-SOD) (FITC)
Description:
Destroys radicals which are normally produced within the cells and which are toxic to biological systems.

Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20C. Aliquots are stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. FITC conjugates are sensitive to light.
TypeIsotypeCloneGrade
PabIgGPurified
SizeStorageShippingSourceHost
50ug-20CBlue IceHumanRabbit
Concentration:
As reported
Immunogen:
Recombinant corresponding to human SOD3.
Purity:
Purified by ammonium sulfate precipitation.
Form
Supplied as a liquid in 0.01M PBS, PH 7.4, 0.03% Proclin 300, 50% glycerol. Labeled with fluorescein isothiocyanate (FITC).
Specificity:
Recognizes human SOD3.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. "Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA." Sherman L., Dafni N., Lieman-Hurwitz J., Groner Y. Proc. Natl. Acad. Sci. U.S.A. 80:5465-5469 (1983). 2. "Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase." Levanon D., Lieman-Hurwitz J., Dafni N., Wigderson M., Sherman L., Bernstein Y., Laver-Rudich Z., Danciger E., Stein O., Groner Y.EMBO J. 4:77-84 (1985). 3. "Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library." Hallewell R.A., Masiarz F.R., Najarian R.C., Puma J.P., Quiroga M.R., Randolph A., Sanchez-Pescador R., Scandella C.J., Smith B., Steimer K.S., Mullenbach G.T.Nucleic Acids Res. 13:2017-2034 (1985).